Clinical Trial

Study of NM8074 in Patients with Dermatomyositis (DM)

Name: Study of NM8074 in Patients with Dermatomyositis (DM) — clinical trial record (NCT06887738)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Phase II, open-label, multicenter study to evaluate the safety and efficacy of NM8074 administered via intravenous infusion in patients with Dermatomyositis (DM).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-13.

Trial Details

NCT Number	NCT06887738
Lead Sponsor	NovelMed Therapeutics
Conditions	Dermatomyositis
Enrollment	8 participants
Start Date	2026-06
Primary Completion	2027-11 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2025-03-25